150 related articles for article (PubMed ID: 8613917)
1. Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors.
O'Hara CM; Uhland-Smith A; O'Malley KL; Todd RD
J Pharmacol Exp Ther; 1996 Apr; 277(1):186-92. PubMed ID: 8613917
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 and D3 receptors inhibit dopamine release.
Tang L; Todd RD; O'Malley KL
J Pharmacol Exp Ther; 1994 Aug; 270(2):475-9. PubMed ID: 8071839
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells.
Yamaguchi I; Walk SF; Jose PA; Felder RA
Mol Pharmacol; 1996 Feb; 49(2):373-8. PubMed ID: 8632772
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.
Tang L; Todd RD; Heller A; O'Malley KL
J Pharmacol Exp Ther; 1994 Jan; 268(1):495-502. PubMed ID: 8301592
[TBL] [Abstract][Full Text] [Related]
5. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA
Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007
[TBL] [Abstract][Full Text] [Related]
6. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
Castellano MA; Liu LX; Monsma FJ; Sibley DR; Kapatos G; Chiodo LA
Mol Pharmacol; 1993 Sep; 44(3):649-56. PubMed ID: 8371717
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2L receptor couples to G alpha i2 and G alpha i3 but not G alpha i1, leading to the inhibition of adenylate cyclase in transfected cell lines.
O'Hara CM; Tang L; Taussig R; Todd RD; O'Malley KL
J Pharmacol Exp Ther; 1996 Jul; 278(1):354-60. PubMed ID: 8764370
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
[TBL] [Abstract][Full Text] [Related]
9. Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines.
Kuzhikandathil EV; Yu W; Oxford GS
Mol Cell Neurosci; 1998 Dec; 12(6):390-402. PubMed ID: 9888991
[TBL] [Abstract][Full Text] [Related]
10. D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations.
Lajiness ME; Chio CL; Huff RM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1573-81. PubMed ID: 7903393
[TBL] [Abstract][Full Text] [Related]
11. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
Kanterman RY; Mahan LC; Briley EM; Monsma FJ; Sibley DR; Axelrod J; Felder CC
Mol Pharmacol; 1991 Mar; 39(3):364-9. PubMed ID: 1848657
[TBL] [Abstract][Full Text] [Related]
12. The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors.
Kuzhikandathil EV; Bartoszyk GD
Neuropharmacology; 2006 Sep; 51(4):873-84. PubMed ID: 16844149
[TBL] [Abstract][Full Text] [Related]
13. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
14. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation- and voltage-dependent inhibition of neuronal calcium currents by activation of human D2(short) dopamine receptors.
Brown NA; Seabrook GR
Br J Pharmacol; 1995 Jun; 115(3):459-66. PubMed ID: 7582457
[TBL] [Abstract][Full Text] [Related]
16. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
Ramanathan S; Tkatch T; Atherton JF; Wilson CJ; Bevan MD
J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
[TBL] [Abstract][Full Text] [Related]
18. Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus.
Romo-Parra H; Aceves J; Gutiérrez R
Hippocampus; 2005; 15(2):254-9. PubMed ID: 15476261
[TBL] [Abstract][Full Text] [Related]
19. Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.
Watts VJ; Neve KA
Mol Pharmacol; 1997 Aug; 52(2):181-6. PubMed ID: 9271339
[TBL] [Abstract][Full Text] [Related]
20. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
